Liver risk under the microscope: TURALIO follow-up study recruits 30 patients
Knowledge-focused
Recruiting now
This study follows up to 30 adults with tenosynovial giant cell tumor (TGCT) who had liver test abnormalities while taking TURALIO (pexidartinib). The goal is to track how often severe liver failure occurs after stopping the drug, and to understand the cause of liver injury throu…
Sponsor: Daiichi Sankyo • Aim: Knowledge-focused
Last updated Apr 26, 2026 20:00 UTC